The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.
Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
Medical equipment and services company Steris (NYSE:STE).
will be reporting earnings this Wednesday after market close. Here’s what investors should know.
STERIS PLC (NYSE:STE) excels in revenue growth, high ROIC, and strong cash flow, making it a top pick for quality investors seeking stable, long-term returns in healthcare.
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 8.6%. This drop was discouraging since the S&P 500 held steady.
Medical equipment and services company Steris (NYSE:STE). missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 4.3% year on year to $1.48 billion. Its non-GAAP EPS of $2.74 per share was 5.4% above analysts’ consensus estimates.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with STERIS (NYSE:STE).
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
Medical equipment and services company Steris (NYSE:STE). met Wall Street’s revenue expectations in Q1 CY2025, with sales up 4.3% year on year to $1.48 billion. Its non-GAAP profit of $2.74 per share was 5.4% above analysts’ consensus estimates.
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
